# Hernia Abd Wall Recons - BDE vs Exparel

> **NCT07518238** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Baylor Research Institute** · enrollment: 128 (estimated)

## Conditions studied

- BDE for Hernia Patients
- Exparel for Hernia Patients

## Interventions

- **DRUG:** BDE Injectable Drug
- **DRUG:** Exparel Injectable Drug

## Key facts

- **NCT ID:** NCT07518238
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-13
- **Primary completion:** 2029-11-12
- **Final completion:** 2029-11-12
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518238, "Hernia Abd Wall Recons - BDE vs Exparel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07518238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*